# Osteolife Biomedical I LLC – FDA Inspection, Feb 4, 2022

Source: https://www.keypedia.com/records/fda_inspections/osteolife-biomedical-i-llc/6bfd2c91-c8f3-4587-9338-090c61ef0329
Source feed: FDA_Inspections

> FDA inspection 1161595 of Osteolife Biomedical I LLC, February 04, 2022. Classification: Official Action Indicated (OAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1161595
- Company Name: Osteolife Biomedical I LLC
- Inspection Date: 2022-02-04
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0
- Enforcement Type: WARNING_LETTER

## Related Documents

- [FDA Inspection 1302716 - 2026-02-13](https://www.keypedia.com/records/fda_inspections/osteolife-biomedical-i-llc/cc42555d-bb87-4991-9795-ca2e6e41f2c6)
- [FDA Inspection 1197358 - 2023-02-14](https://www.keypedia.com/records/fda_inspections/osteolife-biomedical-i-llc/eef2a42a-0d42-4d5a-a386-6797bcbfc617)
- [FDA Inspection 1072837 - 2018-11-28](https://www.keypedia.com/records/fda_inspections/osteolife-biomedical-i-llc/32fed49c-542d-4511-bac7-6f630477eced)

Company: https://www.keypedia.com/companies/osteolife-biomedical-i-llc/65c313b4-28a5-4ecc-875c-ac366081fdc2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d